Search results for: Market Access
Filter search results
The Precautionary Principle in Healthcare
15 June 2016
…pandemic. It would have also allowed a more rapid response to combat the Zika virus, well before it was known with greater scientific certainty that it causes birth defects. Access…
OHE Lunchtime Seminar on 21 September 2016: Health Economic Evaluation throughout the Ages
8 September 2016
…of Melbourne, Australia. His broader health economic research interests include developing methods to value the benefits of improving access to health care, health inequalities, the use of simulation models in…
OHE at Priorities 2016: Valuing Health at the End of Life and MCDA for Priority Setting
19 September 2016
…that for other types of patients? This work was also the subject of a previous OHE blog post. Access Koonal’s presentation below. Does society wish to prioritise end-of-life treatments over…
2024 Innovation Policy Prize
…access to advanced pharmaceuticals for the poor worldwide. His publications include Pro-Poor Mountain Tourism, Routledge 2024; Designing in Ethics, co-edited, Cambridge 2017; Global Tax Fairness, co-edited, Oxford 2016; Politics as…
Measuring and Valuing Outcomes
…submission to the UK Parliamentary Inquiry on an Ageing Society OHE’s written submission to parliament focused on raising population health in older age and increasing access to fertility treatments as…
About us
…subsidiary, OHE Consulting Ltd, OHE provides Contract Research services allowing organisations around the world to access the talent and resources of world-leading team of researchers. All of the proceeds of…
A New Valuation Method: Directly Eliciting Personal Utility Functions
30 August 2017
…University of Technology Sydney, Krystallia Pantiri of Pharmerit, and Professor Ben van Hout of Pharmerit and the University of Sheffield. Preliminary findings were presented at the 2016 PROMs conference. Access…
What Determines Health Care Expenditure in High Income Countries?
18 September 2017
…paper are those of the authors and are not necessarily those of the Health Foundation. The full article is available here [open access] For more details please contact Dr Yan Feng….
OHE Lunchtime Seminar: The UK Biotech Sector and Brexit: Past Performance and Future Prospects
25 September 2017
…benefits of EU membership, including access to EU funding for R & D, be offset by the greater freedom which UK governments will enjoy to support the domestic biotech sector?…